REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,247 | +3.5% | 3,152 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $84,316 | +175558.3% | 3,152 | +42.6% | 0.00% | – |
| Q1 2023 | $48 | -9.4% | 2,210 | 0.0% | 0.00% | – |
| Q4 2022 | $53 | -99.9% | 2,210 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +7.1% | 2,210 | +2.8% | 0.00% | – |
| Q2 2022 | $42,000 | +16.7% | 2,150 | +53.6% | 0.00% | – |
| Q1 2022 | $36,000 | -29.4% | 1,400 | -41.2% | 0.00% | – |
| Q4 2021 | $51,000 | -25.0% | 2,380 | -3.6% | 0.00% | – |
| Q3 2021 | $68,000 | -12.8% | 2,470 | 0.0% | 0.00% | – |
| Q2 2021 | $78,000 | +13.0% | 2,470 | +64.7% | 0.00% | – |
| Q1 2021 | $69,000 | +16.9% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $59,000 | -7.8% | 1,500 | -18.0% | 0.00% | -100.0% |
| Q3 2020 | $64,000 | – | 1,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |